Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 1 Locally Advanced Non-Small Cell Lung Cancer 1 Liver Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 24 Mycophenolic Acid 15 fludarabine phosphate 14 fludarabine 13 Whole-Body Irradiation 13 Tacrolimus 12 Rituximab 12 Melphalan 12 Filgrastim 11 Cyclosporine 11 Busulfan 11 Radiotherapy 10 Peripheral Blood Stem Cell Transplantation 10 Antilymphocyte Serum 10 Methotrexate 9 Doxorubicin 9 Gemcitabine 8 Etoposide 8 Brentuximab Vedotin 8 Sirolimus 7 pembrolizumab 6 Vinblastine 6 Nivolumab 6 Methylprednisolone 6 Granulocyte Colony-Stimulating Factor 6 Alemtuzumab 6 Dacarbazine 5 Cytarabine 5 Cord Blood Stem Cell Transplantation 5 Carmustine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hodgkin Disease × Protons × Clear all

NCT02070393 2015-02-04

Breast Sparing

Indiana University

Phase EARLY_PHASE1 Terminated

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡